- Home
- PBHC vs HRTX Comparison
PBHC vs HRTX Comparison
Compare PBHC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBHC | HRTX |
|---|---|---|
| Founded | 1859 | 1983 |
| Country | United States | United States |
| Employees | N/A | 128 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.8M | 90.1M |
| IPO Year | 2014 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PBHC | HRTX |
|---|---|---|
| Price | $16.26 | $0.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 22.6K | ★ 3.4M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | ★ 46.25 | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | N/A | ★ $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | $34.30 | ★ N/A |
| Revenue Growth | N/A | ★ 7.36 |
| 52 Week Low | $12.06 | $0.38 |
| 52 Week High | $17.40 | $1.99 |
Technical Indicators
Market Signals| Indicator | PBHC | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 48.13 |
| Support Level | $13.74 | $0.38 |
| Resistance Level | $17.17 | $0.87 |
| Average True Range (ATR) | 0.78 | 0.03 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 50.31 | 74.69 |
Price Performance
Historical ComparisonAbout PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.